| ARES |
Ares Management Corp |
Phillips Jarrod |
Officer
|
2026-01-31 |
A - A |
100,000 |
0.00 |
0.00 |
343,377 |
| ARES |
Ares Management Corp |
Phillips Jarrod |
Officer
|
2026-01-31 |
F - D |
15,568 |
149.67 |
2,330,062.56 |
327,809 |
| ARES |
Ares Management Corp |
Arougheti Michael J |
Director
Officer
|
2026-01-31 |
A - A |
200,000 |
0.00 |
0.00 |
1,600,000 |
| ARES |
Ares Management Corp |
Arougheti Michael J |
Director
Officer
|
2026-01-31 |
F - D |
152,495 |
149.67 |
22,823,926.65 |
1,447,505 |
| AVIR |
Atea Pharmaceuticals, Inc. |
Foster Wayne |
|
2026-01-31 |
M - A |
41,333 |
0.00 |
0.00 |
91,461 |
| AVIR |
Atea Pharmaceuticals, Inc. |
Foster Wayne |
|
2026-01-31 |
F - D |
12,132 |
4.24 |
51,439.68 |
79,329 |
| AVIR |
Atea Pharmaceuticals, Inc. |
Foster Wayne |
|
2026-01-31 |
M - D |
33,333 |
0.00 |
0.00 |
0 |
| AVIR |
Atea Pharmaceuticals, Inc. |
Foster Wayne |
|
2026-01-31 |
M - D |
8,000 |
0.00 |
0.00 |
0 |
| AVIR |
Atea Pharmaceuticals, Inc. |
Foster Wayne |
|
2026-01-31 |
A - A |
108,000 |
0.00 |
0.00 |
108,000 |
| AVIR |
Atea Pharmaceuticals, Inc. |
Sommadossi Jean-Pierre |
|
2026-01-31 |
M - A |
272,983 |
0.00 |
0.00 |
573,923 |
| AVIR |
Atea Pharmaceuticals, Inc. |
Sommadossi Jean-Pierre |
|
2026-01-31 |
F - D |
106,093 |
4.24 |
449,834.32 |
467,830 |
| AVIR |
Atea Pharmaceuticals, Inc. |
Sommadossi Jean-Pierre |
|
2026-01-31 |
M - D |
173,466 |
0.00 |
0.00 |
0 |
| AVIR |
Atea Pharmaceuticals, Inc. |
Sommadossi Jean-Pierre |
|
2026-01-31 |
M - D |
99,517 |
0.00 |
0.00 |
0 |
| AVIR |
Atea Pharmaceuticals, Inc. |
Corcoran Andrea |
|
2026-01-31 |
M - A |
54,866 |
0.00 |
0.00 |
779,680 |
| AVIR |
Atea Pharmaceuticals, Inc. |
Corcoran Andrea |
|
2026-01-31 |
F - D |
16,104 |
4.24 |
68,280.96 |
763,576 |
| AVIR |
Atea Pharmaceuticals, Inc. |
Corcoran Andrea |
|
2026-01-31 |
M - D |
44,366 |
0.00 |
0.00 |
0 |
| AVIR |
Atea Pharmaceuticals, Inc. |
Corcoran Andrea |
|
2026-01-31 |
M - D |
10,500 |
0.00 |
0.00 |
0 |
| AVIR |
Atea Pharmaceuticals, Inc. |
Corcoran Andrea |
|
2026-01-31 |
A - A |
180,000 |
0.00 |
0.00 |
180,000 |
| AVIR |
Atea Pharmaceuticals, Inc. |
Hammond Janet MJ |
|
2026-01-31 |
M - A |
58,050 |
0.00 |
0.00 |
141,801 |
| AVIR |
Atea Pharmaceuticals, Inc. |
Hammond Janet MJ |
|
2026-01-31 |
F - D |
14,136 |
4.24 |
59,936.64 |
127,665 |
| AVIR |
Atea Pharmaceuticals, Inc. |
Hammond Janet MJ |
|
2026-01-31 |
M - D |
46,800 |
0.00 |
0.00 |
0 |
| AVIR |
Atea Pharmaceuticals, Inc. |
Hammond Janet MJ |
|
2026-01-31 |
M - D |
11,250 |
0.00 |
0.00 |
0 |
| AVIR |
Atea Pharmaceuticals, Inc. |
Hammond Janet MJ |
|
2026-01-31 |
A - A |
177,000 |
0.00 |
0.00 |
177,000 |
| AVIR |
Atea Pharmaceuticals, Inc. |
Vavricka John |
|
2026-01-31 |
M - A |
42,083 |
0.00 |
0.00 |
94,164 |
| AVIR |
Atea Pharmaceuticals, Inc. |
Vavricka John |
|
2026-01-31 |
F - D |
11,570 |
4.24 |
49,056.80 |
82,594 |